AVL9

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, AVL9 mutation is significantly associated with the RNA expression of many other genes, with 790 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible AVL9-associated genes across cancer lineages are IGLVVI-25-1, ST6GALNAC2P1, and RNU6-461P. Each is linked with AVL9 in more than 2 cancer types. Because this analysis shows association rather than direction, both AVL9-to-partner and partner-to-AVL9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IGLVVI-25-1 grouped by AVL9-low versus AVL9-high in BRCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (AVL9→partner) and Y-score (partner→AVL9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAIGLVVI-25-1 →+0.121+4.711<.001.00433
BRCAST6GALNAC2P1 →+0.036+4.786.007.00433
LGGRNU6-461P →+0.303+7.977<.001.00732
LGGRNU6-715P →+0.313+7.977<.001.00732
UCECTRAJ12 →+0.738+2.581<.001<.00132
UCECIGHD2-2 →+1.388+2.387<.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 790 associations by consensus.

IGLVVI-25-1 by AVL9 expression — BRCA

Box plot of IGLVVI-25-1 in AVL9-low vs AVL9-high samples in BRCA.

Explore this box plot interactively →

Exploration